Lidings Partner Stepan Guzey Takes Part in International Trade Legal Day
Lidings’ dispute resolution practice partner Stepan Guzey will take part in the International Trade Legal Day organized by ICC Russia.
Lidings’ dispute resolution practice partner Stepan Guzey will take part in the International Trade Legal Day organized by ICC Russia.
Starting from August 24, 2021, amendments1 to the Federal Law “On Foreign Investments in the Russian Federation” regarding the procedure for accreditation of branches and representative offices (RO) of foreign legal entities will come into force.
Lidings’ managing partner Andrey Zelenin will take part in the round table discussion Pharmaceutical Industry in International Trade: Challenges and Prospects organized by ICC Russia.
Russian federal service for surveillance in healthcare (Roszdravnadzor) presented an overview of its control and supervisory activities for 2020. Below are the main conclusions of the Overview.
March 11, 2021 Pravo.ru-300 released its individual rating of lawyers. Based on the new rating Lidings managing partner Andrey Zelenin, partners Stepan Guzey and Alexander Popleyuk take top positions in key practice areas.
Since 1 March 2021, the Pharmaceutical Register of the Eurasian Patent Office (EAPO) is available on the official website of the Eurasian Patent Office. The Register contains information on Eurasian patents protecting active substances of drugs.
Lidings’ criminal defense practice partner Stepan Guzey will take part in the online discussion White Collar Crime 2020 devoted to white collar criminal defense.
Chambers and Partners Global has announced the results of its annual research of the leading legal advisors around the world. Lidings’ is recommended among the top legal advisors in intellectual property in Russia.
The rating particularly states that Andrey is “well versed in all aspects of intellectual property and can hammer out favourable outcomes in difficult disputes in the life sciences, fast-moving consumer goods and high-technology spheres” and Boris is “a trusted adviser to numerous pharmaceutical companies on both the patent and trademark sides, and has further know-how in advertising and data protection.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.